Adaptimmune
William Bertrand is currently the Chief Operating Officer at Adaptimmune US. William also serves as a Board Member at Ardelyx, Inc. and previously held roles such as EVP, GC at Infinity Pharmaceuticals and General Manager at Salix Pharmaceuticals. William Bertrand has a strong legal background and has held various legal and executive positions in companies such as MedImmune, Pharmacia, and Dickinson Wright PLLC.
Adaptimmune
2 followers
Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment